Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Muhammad Furqan, Yamei Chen, Akintunde Akinleye, Judy Sarungbam, Alan Gass, Karen Seiter, Delong Liu

Research output: Contribution to journalArticle

Abstract

Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term "mantle cell lymphoma" in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.

Original languageEnglish (US)
Pages (from-to)254-258
Number of pages5
JournalFrontiers of Medicine in China
Volume8
Issue number2
DOIs
StatePublished - Jun 2014

Keywords

  • bendamustine
  • cardiogenic shock
  • mantle cell lymphoma

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock'. Together they form a unique fingerprint.

  • Cite this

    Furqan, M., Chen, Y., Akinleye, A., Sarungbam, J., Gass, A., Seiter, K., & Liu, D. (2014). Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock. Frontiers of Medicine in China, 8(2), 254-258. https://doi.org/10.1007/s11684-014-0319-1